Metastatic Breast Cancer | Tumor

CURE’s metastatic breast cancer page features the latest cancer news and updates on metastatic breast cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in metastatic breast cancer.

My 11-Year Metastatic Breast Cancer Story Defied the Standard Path

April 21st 2025, 5:00pm

Article

Diagnosed in 2014, I share my unique aggressive treatment journey over 11 years, highlighting a common hope for more time and better treatments.

Bria-IMT Combo Outperforms Other Metastatic Breast Cancer Treatments

April 16th 2025, 4:00pm

Article

Bria-IMT plus check point inhibitors had a median overall survival which outperformed that of antibody-drug conjugates in HR+ metastatic breast cancer.

Unraveling Disparities and Genomic Advances Across Breast Cancer Care

March 23rd 2025, 6:00pm

Article

Dr. Regina Hampton shares case studies from her own practice, illustrating how genomic insights have improved patient outcomes in those with breast cancer.

What Patients With Breast Cancer Need to Know About Itovebi

March 20th 2025, 7:05pm

Article

Itovebi, approved for some patients with breast cancer, is the first PI3K inhibitor to display a survival benefit, according to Dr. Kevin Kalinsky.

The Role of Circulating Tumor DNA in Breast Cancer Monitoring

March 18th 2025, 1:00pm

Video

Dr. Debu Tripathy discusses recent research on the use of circulating tumor DNA in metastatic breast cancer care.

Ongoing Trials Aim to Advance HER2-Negative Breast Cancer Treatment

March 15th 2025, 6:00pm

Article

Dr. Kevin Kalinsky covers the gamut of the current treatment landscape for patients with HER2-negative breast cancer, highlighting recent advancements.

First Patients Enrolled in Trial on Anti-HER2 Therapy in HER2+ Breast Cancer

March 12th 2025, 4:00pm

Article

The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ breast cancer using circulating tumor DNA.

Vepdegestrant May Reduce Disease Progression in Breast Cancer Subset

March 11th 2025, 4:14pm

Article

Vepdegestrant improved progression-free survival in patients with estrogen receptor 1 mutations in advanced ER-positive, HER2-negative breast cancer.

Camizestrant Combo Improves Progression Time in HR+/HER2– Breast Cancer

March 1st 2025, 3:00pm

Article

Camizestrant with a CDK 4/6 inhibitor had a statistically significant and clinically meaningful improvement in PFS in HR+/HER2– advanced breast cancer.

Metronomic Capecitabine and an AI Improve Survival in HR+/HER2– Metastatic Breast Cancer

February 27th 2025, 2:00pm

Article

Metronomic capecitabine plus an aromatase inhibitor improved survival outcomes in hormone receptor-positive, HER2-negative metastatic breast cancer.